The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Corporationshionogi.comSince 2026-10-04
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Celaid Therapeutics A biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs) | Series B ext. Verified against 1 of 15 sources | $2.5M | 2026-10-04 | [ PART ] |